Given the key role of PPAR in the transcriptional regulation of glucose and lipid metabolism, PPAR ligands have been investigated also as possible therapeutic agents for fibrotic MASLD.29 The gene discussed is PPARA; the disease is metabolic dysfunction-associated steatotic liver disease.